LoginRegister

    Cipla gets 12 USFDA observations for Goa facility

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  

    "The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019," Cipla said in a filing.


    New Delhi: Drugmaker Cipla announced that the US health regulator has completed the inspection of its manufacturing facility at Goa with 12 observations.


    The inspection of the facility was conducted from September 16 2019, till September 27 2019.


    "The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019," Cipla said in a filing.


    "The inspection ended with 12 observations, none of which are related to data integrity. The Company will respond to the agency within the stipulated timeline," the company added.


    Read Also: Cipla launches skin treatment Daptomycin Injection in the US


    Headquartered in Mumbai, Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.


    Read Also: Cipla employee settles a case with SEBI, pays Rs 3 lakh

    +USFDA ObservationcGMPCiplacipla inspectionIQVIApharmapharma companypharma newsSEBIUnited States Food and Drug AdministrationUSFDAUSFDA inspection

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X